Literature DB >> 27149430

Optimizing dialysate potassium.

Jennifer Lee1, David C Mendelssohn2.   

Abstract

Potassium shifts in thrice weekly HD patients are likely a reversible cause of arrhythmia and sudden cardiac death. In general, a dialysate potassium <2.0 mmol/L should be avoided, and many patients with dialysate potassium of 2 mmol/L could safely be adjusted upwards. The ideal predialysis serum potassium should be around 5.0 mmol/L. Trends in serum potassium and not single values, should inform chronic changes of dialysate potassium prescription. Atypical values should be dealt with as a one off, but should not lead to chronic bath changes. Referral to a renal dietician for counseling to limit dietary potassium intake is vital to prevent recurrence of these atypical episodes. Finally, facilities should develop and implement a formal and reliable way to alert the physician about possible potassium bath mismatching. This facility level approach works best if a policy is developed and endorsed by all involved stakeholders.
© 2016 International Society for Hemodialysis.

Entities:  

Keywords:  Quality improvement; cardiovascular; complications; medical director issues; patient safety

Mesh:

Substances:

Year:  2016        PMID: 27149430     DOI: 10.1111/hdi.12422

Source DB:  PubMed          Journal:  Hemodial Int        ISSN: 1492-7535            Impact factor:   1.812


  3 in total

Review 1.  Dialysate potassium concentration: Should mass balance trump electrophysiology?

Authors:  Patrick H Pun
Journal:  Semin Dial       Date:  2018-07-19       Impact factor: 3.455

Review 2.  Dialysate Potassium, Dialysate Magnesium, and Hemodialysis Risk.

Authors:  Patrick H Pun; John P Middleton
Journal:  J Am Soc Nephrol       Date:  2017-10-09       Impact factor: 10.121

3.  A simple modification of dialysate potassium: its impact on plasma potassium concentrations and the electrocardiogram.

Authors:  Pierre Delanaye; François Krzesinski; Bernard E Dubois; Alexandre Delcour; Sébastien Robinet; Caroline Piette; Jean-Marie Krzesinski; Patrizio Lancellotti
Journal:  Clin Kidney J       Date:  2019-11-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.